ES2180201T3 - Derivados de azetidinona para el tratamiento de infecciones por hcmv. - Google Patents
Derivados de azetidinona para el tratamiento de infecciones por hcmv.Info
- Publication number
- ES2180201T3 ES2180201T3 ES98947256T ES98947256T ES2180201T3 ES 2180201 T3 ES2180201 T3 ES 2180201T3 ES 98947256 T ES98947256 T ES 98947256T ES 98947256 T ES98947256 T ES 98947256T ES 2180201 T3 ES2180201 T3 ES 2180201T3
- Authority
- ES
- Spain
- Prior art keywords
- lower alkyl
- het
- hydrogen
- optionally substituted
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Un compuesto de la fórmula I en el que R1 es hidrógeno, metilo, etilo, metoxi o metiltio; R2 y R3 son cada uno independientemente hidrógeno o alquilo inferior; R4 es hidrógeno o alquilo inferior; R5 es alquilo inferior, cicloalquilo inferior, CH2C(O)OR6 en el que R6 es metilo, etilo o fenilmetilo; fenilo, fenilo monosustituido, disustituido o trisustituido, con un sustituyente seleccionado independientemente de un grupo consistente en alquilo inferior, alcoxi inferior, alquiltio inferior, halo, hidroxi y amino; fenil (alquilo inferior), fenil (alquilo inferior) monosustituido o disustituido en su parte de fenilo con un sustituyente seleccionado independientemente del grupo consistente en alquilo inferior, alcoxi inferior, alquiltio inferior, halo, hidroxi, nitro, amino, alquilamino inferior, di(alquilo inferior)amino, acilamino inferior, di(alquilo inferior)aminocarbonilo, ciano, trifluorometilo, (trifluorometil)tio, (trifluorometil)sulfinilo, (trifluorometil)sulfonilo y C(O)OR7 en la que R7 es metilo, etilo o fenilmetilo; Het o Het(alquilo inferior) en el que Het es 2-furilo, 2- metil-3-furilo, 2-tienilo, 2-piridinilo, 3-piridinilo, 4- piridinilo, 3-metil-2-pirrolilo, 2-tiazolilo, 4-tiazolilo, 2-isoxazolilo, 2-pirimidinilo, 4-metil-2-pirimidinilo, 4,6- dimetil-2-pirimidinilo, 4-pirimidinilo, 2,6-dimetil-2- pirimidinilo, 4-metiltetrazolilo, 2-benzotiazolilo o 2- tiazolo[4,5-b]piridinilo; (5-benzo[1,3]dioxolil)metilo, 1(R)-(1-naftalenil)-etilo; o R4 y R5 junto con el átomo de nitrógeno al que están unidos, forman pirrolidino, piperidino, morfolino, N- metilpiperazino, 1-(3,4-dihidro-1H-isoquinolinilo) o 2-(3,4- dihidro-1H-isoquinolinilo); y Z es alquilo inferior, fenilo, fenilo monosustituido o disustituido con un sustituyente seleccionado independientemente de alquilo inferior, alcoxi inferior, halo, hidroxi y amino; fenilmetilo, fenilmetilo monosustituido o disustituido en su parte de fenilo con un sustituyente seleccionado de un grupo consistente en alquilo inferior, alcoxiinferior, halo, hidroxi y amino; o (CH2)p-(Het) en el que p es el número entero 0 o 1, y Het es como se ha definido aquí; en el que la expresión "alquilo inferior" sola o en combinación con otro radical, significa radicales de cadena alquilo lineal o ramificada, que contienen hasta 6 átomos de carbono; la expresión "alcoxi inferior" significa radicales de cadena alcoxi lineal, que contienen de uno a cuatro átomos de carbono, y radicales de cadena alcoxi ramificada que contienen de tres a cuatro átomos de carbono; la expresión "alcanoílo inferior" sola o en combinación con otro radical, significa una cadena de 1-oxoalquilo lineal que contiene de uno a seis átomos de carbono o una cadena de 1-oxoalquilo ramificada que contiene de cuatro a seis átomos de carbono; y la expresión -cicloalquilo inferior- sola o en combinación con otro radical, significa radicales hidrocarbonados cíclicos saturados que contienen de tres a siete átomos de carbono; con la condición de que cuando Z es (CH2)p-(Het) como aquí se define, entonces R2 y R3 son cada uno hidrógeno; o una de sus sales de adición de ácido terapéuticamente aceptables.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US6154497P | 1997-10-07 | 1997-10-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2180201T3 true ES2180201T3 (es) | 2003-02-01 |
Family
ID=22036448
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES98947256T Expired - Lifetime ES2180201T3 (es) | 1997-10-07 | 1998-10-06 | Derivados de azetidinona para el tratamiento de infecciones por hcmv. |
Country Status (11)
Country | Link |
---|---|
US (1) | US6242439B1 (es) |
EP (1) | EP1021405B1 (es) |
JP (1) | JP2001519329A (es) |
AT (1) | ATE224872T1 (es) |
AU (1) | AU9426098A (es) |
CA (1) | CA2301543C (es) |
DE (1) | DE69808326T2 (es) |
DK (1) | DK1021405T3 (es) |
ES (1) | ES2180201T3 (es) |
PT (1) | PT1021405E (es) |
WO (1) | WO1999018072A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ527852A (en) | 2001-03-28 | 2005-03-24 | Schering Corp | Enantioselective synthesis of azetidinone intermediate compounds |
DE10134478B4 (de) * | 2001-07-16 | 2007-10-31 | Priaton Gmbh | Verfahren zur Darstellung von thiazolsubstituierten β-Lactamen |
US20080264095A1 (en) * | 2005-03-09 | 2008-10-30 | Combs Steven Larue | Cold Room With Roof-Top Support Platform |
WO2010027951A1 (en) * | 2008-09-02 | 2010-03-11 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for inhibiting entry of a hepatic virus |
JP7273951B2 (ja) | 2018-09-12 | 2023-05-15 | ノバルティス アーゲー | 抗ウイルス性ピリドピラジンジオン化合物 |
CN114667285A (zh) | 2019-09-26 | 2022-06-24 | 诺华股份有限公司 | 抗病毒吡唑并吡啶酮化合物 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5229381A (en) * | 1983-12-01 | 1993-07-20 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
US4680391A (en) | 1983-12-01 | 1987-07-14 | Merck & Co., Inc. | Substituted azetidinones as anti-inflammatory and antidegenerative agents |
NZ228600A (en) * | 1988-04-11 | 1992-02-25 | Merck & Co Inc | 1-(benzylaminocarbonyl)-4-phenoxy-azetidin-2-one derivatives |
DE377549T1 (de) | 1989-01-03 | 1990-11-08 | Marcos Y. Southbridge Mass. Kleinerman | Fernmessung physikalischer variablen mit faseroptischen systemen. |
US5100880A (en) * | 1991-03-20 | 1992-03-31 | Merck & Co., Inc. | Novel betalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone |
US5104862A (en) * | 1991-03-20 | 1992-04-14 | Merck & Co., Inc. | Bethalactam elastase inhibitors containing phosphorous acid derivatives at the 4-position of the 2-azetidinone |
US5229831A (en) | 1991-09-20 | 1993-07-20 | The Charles Stark Draper Laboratory, Inc. | Ultraminiature tactical grade cryogenic RFOG |
GB2266527A (en) * | 1992-03-17 | 1993-11-03 | Merck & Co Inc | Substituted azetidinones useful in the treatment of leukemia |
GB9314350D0 (en) * | 1993-07-12 | 1993-08-25 | Zeneca Ltd | Armide derivatives |
CA2186111A1 (en) * | 1994-03-23 | 1995-09-28 | Hiroshi Kido | Novel remedy for respiratory-tract viral disease |
-
1998
- 1998-10-06 US US09/167,143 patent/US6242439B1/en not_active Expired - Lifetime
- 1998-10-06 AT AT98947256T patent/ATE224872T1/de active
- 1998-10-06 DE DE69808326T patent/DE69808326T2/de not_active Expired - Lifetime
- 1998-10-06 ES ES98947256T patent/ES2180201T3/es not_active Expired - Lifetime
- 1998-10-06 DK DK98947256T patent/DK1021405T3/da active
- 1998-10-06 PT PT98947256T patent/PT1021405E/pt unknown
- 1998-10-06 WO PCT/CA1998/000953 patent/WO1999018072A1/en active IP Right Grant
- 1998-10-06 AU AU94260/98A patent/AU9426098A/en not_active Abandoned
- 1998-10-06 CA CA002301543A patent/CA2301543C/en not_active Expired - Fee Related
- 1998-10-06 EP EP98947256A patent/EP1021405B1/en not_active Expired - Lifetime
- 1998-10-06 JP JP2000514884A patent/JP2001519329A/ja not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
JP2001519329A (ja) | 2001-10-23 |
DE69808326D1 (de) | 2002-10-31 |
CA2301543A1 (en) | 1999-04-15 |
ATE224872T1 (de) | 2002-10-15 |
EP1021405B1 (en) | 2002-09-25 |
US6242439B1 (en) | 2001-06-05 |
DE69808326T2 (de) | 2003-05-22 |
WO1999018072A1 (en) | 1999-04-15 |
AU9426098A (en) | 1999-04-27 |
PT1021405E (pt) | 2003-02-28 |
DK1021405T3 (da) | 2003-02-03 |
CA2301543C (en) | 2005-05-17 |
EP1021405A1 (en) | 2000-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS20060079A (en) | Novel compounds having inhibitory activity against sodium-dependant transporter | |
NZ514095A (en) | Amide compounds and medicinal use thereof | |
NZ511739A (en) | New esters derived from substituted phenyl-cyclohexyl compounds | |
GB9910580D0 (en) | Chemical compounds | |
MY111814A (en) | Watersoluble azole antifungals | |
DK0918776T3 (da) | Totalsyntese af antitumor acylfulvener | |
EP0614661A3 (en) | Benzylidene and cinnamylidene malononitrile derivatives to inhibit proliferative processes in mammalian cells. | |
CA2152902A1 (fr) | Ligands selectifs des recepteurs 5-ht1d-5ht1b derives d'indole-piperazine utiles comme medicaments | |
DK1202954T3 (da) | Nye aminobenzophenoner | |
AP9901578A0 (en) | Sulfonylbenzene compounds as anti-inflammatory/analgesic agents. | |
TR200100603T2 (tr) | Pirazin bileşikleri | |
ATE57930T1 (de) | Dihydropyridine. | |
ES2180201T3 (es) | Derivados de azetidinona para el tratamiento de infecciones por hcmv. | |
DK1023265T3 (da) | Azetidinonderivater til behandlingen af HCMV infektioner | |
PT1021404E (pt) | Derivados de azetidinona para o tratamento de infeccoes pelo hcmv | |
ES471895A1 (es) | Procedimiento para preparar derivados de benzamidina | |
IL107389A (en) | N-substituted carbonyloxyalkyl- pyrroles and insecticidal, acaricidal and molluscicidal compositions containing them | |
DE3870468D1 (de) | Ergolinylheterocyclen. | |
ES2182775T3 (es) | Derivados de ciclohexano 1,4-disustituidos para el tratamiento de la depresion. | |
TH25925A (th) | สารประกอบชนิดใหม่ |